• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High-throughput "read-on-ski" automated imaging and label-free detection system for toxicity screening of compounds using personalised human kidney organoids.高通量“读雪”自动化成像和无标记检测系统,用于使用个性化人类肾类器官对化合物进行毒性筛选。
J Zhejiang Univ Sci B. 2022 Jul 15;23(7):564-577. doi: 10.1631/jzus.B2100701.
2
Advancing preclinical drug evaluation through automated 3D imaging for high-throughput screening with kidney organoids.通过 3D 成像自动化技术推进临床前药物评估,实现高通量筛选的肾类器官。
Biofabrication. 2024 Apr 8;16(3). doi: 10.1088/1758-5090/ad38df.
3
High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping.高通量筛选增强了人多能干细胞向肾类器官的分化并实现了多维表型的自动化分析。
Cell Stem Cell. 2018 Jun 1;22(6):929-940.e4. doi: 10.1016/j.stem.2018.04.022. Epub 2018 May 17.
4
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.OrBITS:用于先进药物筛选的患者来源类器官的无标记和延时监测。
Cell Oncol (Dordr). 2023 Apr;46(2):299-314. doi: 10.1007/s13402-022-00750-0. Epub 2022 Dec 12.
5
Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology.多能干细胞衍生的肾脏类器官:一种类似体内环境的体外技术。
Eur J Pharmacol. 2016 Nov 5;790:12-20. doi: 10.1016/j.ejphar.2016.06.059. Epub 2016 Jul 1.
6
ATP/ADP biosensor organoids for drug nephrotoxicity assessment.用于药物肾毒性评估的ATP/ADP生物传感器类器官
Front Cell Dev Biol. 2023 Mar 2;11:1138504. doi: 10.3389/fcell.2023.1138504. eCollection 2023.
7
In Situ Detection of Kidney Organoid Generation From Stem Cells Using a Simple Electrochemical Method.利用简单的电化学方法原位检测干细胞生成的类器官肾脏。
Adv Sci (Weinh). 2022 Jul;9(20):e2200074. doi: 10.1002/advs.202200074. Epub 2022 May 4.
8
Three-Dimensional Renal Organoids from Whole Kidney Cells: Generation, Optimization, and Potential Application in Nephrotoxicology In Vitro.从全肾细胞生成的三维肾类器官:生成、优化及在体外肾毒理学中的潜在应用
Cell Transplant. 2020 Jan-Dec;29:963689719897066. doi: 10.1177/0963689719897066.
9
11.7T Diffusion Magnetic Resonance Imaging and Tractography to Probe Human Brain Organoid Microstructure.11.7T扩散磁共振成像和纤维束成像用于探究人脑类器官的微观结构。
Biol Psychiatry Glob Open Sci. 2024 Jun 7;4(5):100344. doi: 10.1016/j.bpsgos.2024.100344. eCollection 2024 Sep.
10
Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation.细胞挤出式生物打印提高了肾类器官的重现性和形态。
Nat Mater. 2021 Feb;20(2):260-271. doi: 10.1038/s41563-020-00853-9. Epub 2020 Nov 23.

引用本文的文献

1
Arsenic-induced nephrotoxicity: Mechanisms, biomarkers, and preventive strategies for global health.砷诱导的肾毒性:全球健康的机制、生物标志物及预防策略
Vet World. 2025 Jul;18(7):2136-2157. doi: 10.14202/vetworld.2025.2136-2157. Epub 2025 Jul 30.
2
Optimizing drug sensitivity assays in patient-derived tumor organoids: a comparison of IC50 estimation methods and experimental parameters.优化患者来源的肿瘤类器官中的药物敏感性测定:IC50估计方法和实验参数的比较
Biol Methods Protoc. 2025 Feb 13;10(1):bpaf012. doi: 10.1093/biomethods/bpaf012. eCollection 2025.
3
Recent advances in extracellular matrix manipulation for kidney organoid research.用于肾类器官研究的细胞外基质操控技术的最新进展
Front Pharmacol. 2024 Nov 6;15:1472361. doi: 10.3389/fphar.2024.1472361. eCollection 2024.
4
Non-invasive label-free imaging analysis pipeline for in situ characterization of 3D brain organoids.用于 3D 脑类器官原位特征分析的无创无标记成像分析流程。
Sci Rep. 2024 Sep 27;14(1):22331. doi: 10.1038/s41598-024-72038-2.
5
Selecting Monoclonal Cell Lineages from Somatic Reprogramming Using Robotic-Based Spatial-Restricting Structured Flow.利用基于机器人的空间限制结构化流动从体细胞重编程中选择单克隆细胞谱系。
Research (Wash D C). 2024 Mar 7;7:0338. doi: 10.34133/research.0338. eCollection 2024.
6
Biomimetic Gland Models with Engineered Stratagems.具有工程策略的仿生腺体模型
Research (Wash D C). 2023 Sep 15;6:0232. doi: 10.34133/research.0232. eCollection 2023.

本文引用的文献

1
Automatic system for high-throughput and high-sensitivity diagnosis of SARS-CoV-2.用于 SARS-CoV-2 高通量和高灵敏度诊断的自动化系统。
Bioprocess Biosyst Eng. 2022 Mar;45(3):503-514. doi: 10.1007/s00449-021-02674-9. Epub 2022 Jan 15.
2
The Dynamics of Metabolic Characterization in iPSC-Derived Kidney Organoid Differentiation a Comparative Omics Approach.诱导多能干细胞衍生的肾类器官分化中代谢特征的动态变化:一种比较组学方法
Front Genet. 2021 Feb 10;12:632810. doi: 10.3389/fgene.2021.632810. eCollection 2021.
3
Human Urinal Cell Reprogramming: Synthetic 3D Peptide Hydrogels Enhance Induced Pluripotent Stem Cell Population Homogeneity.人类尿液细胞重编程:合成 3D 肽水凝胶增强诱导多能干细胞群体的均一性。
ACS Biomater Sci Eng. 2020 Nov 9;6(11):6263-6275. doi: 10.1021/acsbiomaterials.0c00667. Epub 2020 Oct 20.
4
Establishment of patient-derived cancer organoids for drug-screening applications.建立用于药物筛选应用的患者来源的癌症类器官。
Nat Protoc. 2020 Oct;15(10):3380-3409. doi: 10.1038/s41596-020-0379-4. Epub 2020 Sep 14.
5
Evaluation of cisplatin-induced injury in human kidney organoids.评估顺铂诱导的人肾类器官损伤。
Am J Physiol Renal Physiol. 2020 Apr 1;318(4):F971-F978. doi: 10.1152/ajprenal.00597.2019. Epub 2020 Mar 9.
6
Stem cell-derived kidney organoids: engineering the vasculature.干细胞衍生的肾脏类器官:血管工程。
Cell Mol Life Sci. 2020 Jun;77(12):2257-2273. doi: 10.1007/s00018-019-03401-0. Epub 2019 Dec 5.
7
Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening.子宫内膜疾病衍生的类器官可捕获临床异质性并适用于药物筛选。
Nat Cell Biol. 2019 Aug;21(8):1041-1051. doi: 10.1038/s41556-019-0360-z. Epub 2019 Aug 1.
8
A Simple Bioreactor-Based Method to Generate Kidney Organoids from Pluripotent Stem Cells.基于简单生物反应器的方法从多能干细胞生成肾类器官。
Stem Cell Reports. 2018 Aug 14;11(2):470-484. doi: 10.1016/j.stemcr.2018.06.018. Epub 2018 Jul 19.
9
Deep Convolutional Neural Networks for breast cancer screening.深度学习卷积神经网络在乳腺癌筛查中的应用。
Comput Methods Programs Biomed. 2018 Apr;157:19-30. doi: 10.1016/j.cmpb.2018.01.011. Epub 2018 Jan 11.
10
A Machine Learning Assisted, Label-free, Non-invasive Approach for Somatic Reprogramming in Induced Pluripotent Stem Cell Colony Formation Detection and Prediction.机器学习辅助、无标记、非侵入性的方法用于体细胞重编程诱导多能干细胞集落形成的检测和预测。
Sci Rep. 2017 Oct 18;7(1):13496. doi: 10.1038/s41598-017-13680-x.

高通量“读雪”自动化成像和无标记检测系统,用于使用个性化人类肾类器官对化合物进行毒性筛选。

High-throughput "read-on-ski" automated imaging and label-free detection system for toxicity screening of compounds using personalised human kidney organoids.

机构信息

State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.

出版信息

J Zhejiang Univ Sci B. 2022 Jul 15;23(7):564-577. doi: 10.1631/jzus.B2100701.

DOI:10.1631/jzus.B2100701
PMID:35794686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9264113/
Abstract

Organoid models are used to study kidney physiology, such as the assessment of nephrotoxicity and underlying disease processes. Personalized human pluripotent stem cell-derived kidney organoids are ideal models for compound toxicity studies, but there is a need to accelerate basic and translational research in the field. Here, we developed an automated continuous imaging setup with the "read-on-ski" law of control to maximize temporal resolution with minimum culture plate vibration. High-accuracy performance was achieved: organoid screening and imaging were performed at a spatial resolution of 1.1 μm for the entire multi-well plate under 3 min. We used the in-house developed multi-well spinning device and cisplatin-induced nephrotoxicity model to evaluate the toxicity in kidney organoids using this system. The acquired images were processed via machine learning-based classification and segmentation algorithms, and the toxicity in kidney organoids was determined with 95% accuracy. The results obtained by the automated "read-on-ski" imaging device, combined with label-free and non-invasive algorithms for detection, were verified using conventional biological procedures. Taking advantage of the close-to-in vivo-kidney organoid model, this new development opens the door for further application of scaled-up screening using organoids in basic research and drug discovery.

摘要

类器官模型用于研究肾脏生理学,例如评估肾毒性和潜在疾病过程。个性化的人多能干细胞衍生的肾脏类器官是化合物毒性研究的理想模型,但需要加速该领域的基础和转化研究。在这里,我们开发了一种自动化连续成像设置,采用“随动滑雪”控制定律,以最小的培养板振动实现最大的时间分辨率。高精度性能得以实现:在 3 分钟内,以 1.1μm 的空间分辨率对整个多孔板进行类器官筛选和成像。我们使用内部开发的多井旋转装置和顺铂诱导的肾毒性模型,使用该系统评估肾脏类器官的毒性。通过基于机器学习的分类和分割算法处理采集到的图像,并以 95%的准确率确定肾脏类器官的毒性。通过自动化的“随动滑雪”成像设备获得的结果,结合用于检测的无标记和非侵入性算法,使用传统的生物学程序进行了验证。利用接近体内的肾脏类器官模型,这一新的发展为使用类器官在基础研究和药物发现中进行规模化筛选开辟了道路。